Houston-based Cemvita Factory announces its initial closing of Series A, led by 8090 Partners, to accelerate industrial decarbonization

New Materials Batch 1 Selected Startup | Cemvita Factory Inc.

Houston-based Cemvita Factory (Cemvita), a leading industrial biotechnology startup that uses innovative synthetic biology to decarbonize heavy industry such as chemical manufacturing, mining, and oil and gas, today announces the initial closing of its Series A financing to accelerate the company’s mission of reversing climate change. The round was led by 8090 Partners, with participation from key existing investor Oxy Low Carbon Ventures (OLCV), along with Seldor Capital, Climate Capital, and others.

Cemvita’s bio-manufacturing platform mitigates emissions resulting from traditionally energy-intensive chemical and catalytic conversion processes by operating under ambient temperature and pressure. Additionally, this same technology is able to turn polymer production into a low carbon activity by utilizing carbon dioxide (CO2) as a feedstock, a crucial step in building a circular carbon economy. Cemvita is currently working with a number of clients in industry to help them use CO2 as a resource to lower their carbon footprint.

Cemvita’s conversion platform leverages the biomimicry of natural processes to sustainably produce chemicals and polymers. Additionally, Cemvita’s biotech platform is used to develop and optimize low carbon bio-extraction processes, such as bioleaching for the mining industry.